NS 2028
CAS: 204326-43-2
Ref. 3D-EIA32643
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Información del producto
- 1H,4H-[1,2,4]Oxadiazolo[3,4-c][1,4]benzoxazin-1-one, 8-bromo-
- 4H-8-Bromo-1,2,4-oxadiazolo(3,4-d)ben(b)(1,4)oxazin-1-one
- 8-Bromo-1H,4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one
- Ns 2028
NS 2028 is an inhibitor of cyclase, a signal transduction protein that is responsible for the conversion of inactive GTP to active cGMP. NS 2028 inhibits the production of cGMP by binding to and blocking the active site on cyclase, which prevents the phosphorylation and activation of downstream cellular proteins. NS 2028 has been shown to inhibit the light-induced oxidative stress response in a human prostate cancer cell line (Du-145) by reducing intracellular calcium levels and inhibiting signal pathways that lead to mitochondrial membrane potential disruption.
Propiedades químicas
Consulta técnica sobre: 3D-EIA32643 NS 2028
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
